Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India
[250 Pages Report] The global vaginitis treatment drugs market is likely to be valued at around US$ 3.01 Bn in 2022. Market growth is expected to progress at 5.2% CAGR to reach US$ 4.52 Bn by the end of 2030.
Attributes | Details |
---|---|
Vaginitis Treatment Drugs Market Size (2022) | US$ 3.01 Billion |
Revenue Forecast (2030) | US$ 4.52 Billion |
Global Market Growth Rate (2022 to 2030) | 5.2% CAGR |
Market Share of Nitroimidazole Compounds | 43.4% |
Vaginitis treatment drug consumption currently accounts for a 7% share in the global antibiotics market. Some of the important reasons driving demand for vaginitis treatment drugs are increased knowledge about women's health, development of new pharmaceuticals by significant businesses, and rising desire for improved healthcare facilities.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 5.13% |
H1, 2022 Projected | 5.23% |
H1, 2022 Outlook | 4.83% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 40 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (-) 30 ↓ |
The comparative analysis and market growth rate of the global vaginitis treatment drugs market as studied by Future Market Insights will show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 40 BPS, and, a negative BPS growth is expected in H1-2022 over H1- 2021 duration with 30 Basis Point Share (BPS).
The market observes a dip in the BPS values owed to the limited number of available therapeutic options for vaginitis. There is also observed, a shortage in the number of products in the upcoming pipeline for vaginitis treatment drugs. This factor has thus contributed towards the negative BPS growth of the market.
The market is subject to regulatory guidelines for drugs and biologics, and clinical safety, as per the macro and industrial standards. The key development in the market includes the introduction of a vaginal tablet with an active substance already approved as a food additive, through the EU-funded NEFERTITI project. The market is set to experience positive growth during the forecast years, owing to the presence of new, available treatments for vaginitis.
Vaginitis is a vaginal irritation that causes discharge, itching, and pain. A change in the balance of vaginal flora or an infection is the most common cause. Vaginitis can be caused by low oestrogen levels after menopause, as well as some skin conditions.
Vaginitis can be caused by a variety of bacterial infections and circumstances, so treatment is based on the exact cause. Bacterial vaginitis, fungal vaginitis (yeast infection), and trichomoniasis are the most frequent kinds of vaginitis. Vaginitis can be treated with a variety of medications.
"Almost every nitroimidazole medicine given orally in a single dosage or over a long period leads to parasitological cure in 90% of instances. A single 2-g dose of metronidazole is sufficient, but it can cause dyspepsia and a metallic taste; compliant patients may choose a lengthier regimen with a lower daily dose and fewer side effects. Bacterial vaginosis and trichomoniasis can be treated with metronidazole at a dose of 500 mg twice weekly. Metronidazole-resistant strains should be treated with 2 to 4 g of metronidazole daily for a week or two," according to aafp.org.
The vaginitis treatment drugs market expanded at a CAGR of 4.2% from 2015 to 2021. The market is expected to grow due to an increase in R&D initiatives for precise diagnosis. Various government and non-government bodies, including the World Health Organization and the European Institute of Women's Health (EIWH), have launched public awareness campaigns about women's health.
The market is being driven by numerous firms' continuous R&D operations, as well as changing lifestyle patterns of women around the world, such as cigarette and alcohol intake.
Demand for vaginitis treatment drugs is expected to expand at a CAGR of 5.2% from 2022 to 2030, with the global market predicted to reach a valuation of US$ 4.52 Bn by 2030.
“Increased Incidence of Infectious Vaginosis and Rising R&D Activities & Public Awareness about Women's Health”
According to University of Cape Town researchers, a vaginal health probiotic including vaginal lactobacillus strains may be a better therapy choice for vaginitis.
This probiotic may also reduce the incidence of STDs and bad pregnancy outcomes, according to the researchers. On these grounds, more expenditure on research in the vaginitis treatment drugs market is expected throughout the forecast period.
Furthermore, expanding healthcare infrastructure in developing economies, availability of pharmaceutical drugs, and robust technological advancements in the biopharmaceutical industries are all contributing to significant opportunities for vaginitis treatment drugs over the forecasted period.
“Asymptomatic Nature of Bacterial Vaginitis & Unawareness of Vaginitis Diagnostic Tests Stunting Demand for Vaginitis Treatment Drugs”
At least half of the female population can suffer from bacterial vaginosis (BV) with no symptoms. Even when asymptomatic, bacterial vaginosis is linked to a high prevalence of pelvic inflammatory illness and endometritis.
The asymptomatic form of vaginosis inhibits the populace from detecting the infection and taking early steps to prevent infection transmission. Antibiotic and antifungal medicine demand are predicted to be hampered by the increasing incidence of asymptomatic vaginitis.
“Developed Healthcare Facilities, High Incidence of Diseases, and Presence of Key Producers in North America Market”
The most profitable market for vaginitis treatment medications in North America. This region's established healthcare infrastructures, as well as the high frequency of disease and the presence of important manufacturers, are major factors contributing towards vaginitis treatment drugs market share.
As manufacturers develop novel vaginal tablets, Europe's vaginitis treatment drugs industry, which accounts for more than one-fourth of worldwide vaginitis treatment revenues, is poised to see lucrative development prospects in the future.
Brazil and South Africa, in addition to these two lucrative markets, provide considerable prospects for vaginitis treatment drug manufacturers.
During the projection period, the Asia Pacific vaginitis treatment medication market is predicted to develop at the fastest rate. This is due to a significant number of unmet clinical requirements, improved knowledge of early diagnosis, and the availability of effective medications.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Rising Number of Vaginitis Cases Driving Demand for OTC Drugs”
The overgrowth of microorganisms (lactobacillus) in the vaginal area upsets the natural balance. Around 33% of women in the United States are impacted by this excess growth, which leads to "Vaginitis."
If left untreated, vaginitis can lead to miscarriages, pre-term babies, and, most importantly, a 2X to 4X higher chance of contracting HIV. Other STDs linked to vaginitis include chlamydia, gonorrhoea, and papillomavirus. Also, infertility can occur at any time.
The aforementioned facts highlight the need for vaginitis treatment. OTC drugs are also included in the vaginitis treatment drugs market. The novel approach for treating vaginitis is "vaginal bacteria transplants." As a result, the vaginitis treatment pharmaceuticals market is likely to experience a surge in innovation over the coming years.
“Rising Awareness of Vaginitis & Availability of Advanced Treatment Aiding Sales of Vaginitis Treatment Drugs”
Vaginitis is a fast-spreading problem among women all over the world, and it is a growing concern in India too.
Bacterial vaginosis is the major cause of vaginitis in women of reproductive age, according to a study published on pathology. med research.in, "In the gynaecological outpatient environment, it is the most prevalent condition. In India, the incidence of bacterial vaginosis in adults ranges from 17.8% to 63.7%.
The report concludes that "Bacterial vaginosis was found to be prevalent in 44.6% of the population. For the diagnosis of bacterial vaginosis, Amsel's criteria were equivalent to Nugent's criteria, and are simple, quick, cost-effective, and trustworthy, and it may be used for precise and quick treatment too".
As a result of greater awareness regarding the early detection of vaginitis and skin cancer, as well as the availability of efficient medications, vaginitis treatment drug sales in India are on the rise.
“Online Pharma Portals Driving Drug Sales of Mail Order Pharmacies”
Hospital pharmacies, drug stores, and mail-order pharmacies all contribute to the overall sales of vaginitis treatment drugs, which are dominated by retail pharmacies. The Covid-19 pandemic has resulted in a spike in drug sales by mail-order pharmacies, which is projected to continue at a rapid pace in the coming years.
More patients are getting their prescription drugs through the mail and various internet outlets. The online pharmacy sector of India witnessed more than 50 plus startups.
“Nitroimidazole Compounds Widely Used Due to Effective Results”
Nitroimidazole compounds account for more than half of the global market share for vaginitis treatment drugs. At present, nitroimidazole compounds are expected to account for 43.4% of the global market share. This could be due to their widespread use and availability, as well as the fact that they are the most widely approved form of vaginitis treatment.
Tinidazole and metronidazole are the most commonly recommended antibiotic compounds for vaginitis treatment. Furthermore, manufacturers have been concentrating on the introduction of novel pharmaceuticals as well as collaborations in this area. In 2022, triazoles and imidazoles are likely to hold 14% and 25.1% of the global market share respectively.
Lincosamide is an antibiotic that is used to treat infections caused by bacteria like pelvic inflammatory disease, stomach infections, abscesses, pimples, and anaerobic infectious diseases. They're typically used to treat serious infections in penicillin-allergic people. Lincosamide antibiotics are bacteriostatic drugs that limit bacterial multiplication by interacting with protein synthesis.
At high antibiotic doses, they may also have a bactericidal (killing) effect against pathogens. Currently, lincosamide antibiotics are predicted to account for 17.5% of the global market share.
The vaginitis treatment drugs market is still largely consolidated. At the worldwide level, there is an influx of unique pharmaceuticals on the market. Competition is intense, with an additional 25+ vaginitis therapy drug players, medication development, clinical trials, and e-commerce.
Because vaginitis has a high recurrence rate, makers of vaginitis treatment drugs are concentrating on the development of non-antibiotic medications for long-term treatment.
Single-dose medications and over-the-counter drugs are being introduced by key companies, allowing for cost-effective treatment. Furthermore, manufacturers are concentrating on forming drug research alliances to expand the pool of more effective pharmaceutical prospects.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2030 |
Historical Data Available for | 2015 to 2021 |
Market Analysis | US$ Billion for Value |
Key Regions Covered |
|
Key Countries Covered |
|
Key Market Segments Covered |
|
Key Companies Profiled |
|
Pricing | Available upon Request |
Vaginitis Treatment Drugs Market by Drug:
Vaginitis Treatment Drugs Market by Indication:
Vaginitis Treatment Drugs Market by Route of Administration:
Vaginitis Treatment Drugs Market by Schedule of Drug:
Vaginitis Treatment Drugs Market by Distribution Channel:
Vaginitis Treatment Drugs Market by Region:
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Innovation / Development Trends 4. Market Context 4.1. Regulatory Scenario 4.2. Pipeline Analysis 4.3. Reimbursement Scenario by Region 4.4. Disease Epidemiology by Region 5. Market Background 5.1. Macro-Economic Factors 5.2. Forecast Factors - Relevance & Impact 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 5.4. Value Chain Analysis 5.5. COVID19 Crisis Analysis 5.5.1. Current COVID19 Statistics and Probable Future Impact 5.5.2. Current GDP Projection and Probable Impact 5.5.3. Current Economic Projection as compared to 2008 Economic analysis 5.5.4. COVID19 and Impact Analysis 5.5.4.1. Revenue By Product 5.5.4.2. Revenue By Country 5.5.5. 2022 Market Scenario 5.5.6. Quarter by Quarter Forecast 5.5.7. Projected recovery Quarter 5.5.8. Recovery Scenario – Short term, Midterm and Long Term Impact 6. Global Vaginitis Treatment Drugs Market Demand (in Value or Size in US$ Mn) Analysis 2015-2021 and Forecast, 2022–2030 6.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 6.2. Current and Future Market Value (US$ Mn) Projections, 2022–2030 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Drug Type 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2015-2021 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2022–2030 7.3.1. Nitroimidazole Compound 7.3.2. Lincosamide Antibiotics 7.3.3. Triazoles 7.3.4. Imidazoles 8. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Indication 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Indication, 2022 – 2030 8.3.1. Bacterial Vaginitis 8.3.2. Fungal Vaginitis (Yeast infection) 8.3.3. Trichomoniasis 9. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Route of Administration 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2015-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast Route of Administration, 2022 – 2030 9.3.1. Oral 9.3.2. Cutaneous 9.3.3. Vaginal 10. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Schedule of Drug 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Schedule of Drug, 2015-2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Schedule of Drug, 2022 – 2030 10.3.1. Prescription Drugs (Rx) 10.3.2. Over the counter Drugs (OTC) 11. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 – 2030 11.3.1. Hospital Pharmacies 11.3.2. Retail Pharmacies 11.3.3. Drug Stores 11.3.4. Mail Order Pharmacy 12. Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2030 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Middle East & Africa 12.4. Market Attractiveness Analysis By Region 13. North America Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030 13.3.1. By Drug Type 13.3.2. By Indication 13.3.3. By Route of Administration 13.3.4. By Schedule of Drug 13.3.5. By Distribution Channel 13.3.6. By Country 13.3.6.1. U.S. 13.3.6.2. Canada 13.4. Market Attractiveness Analysis 13.4.1. By Drug Type 13.4.2. By Indication 13.4.3. By Route of Administration 13.4.4. By Schedule of Drug 13.4.5. By Distribution Channel 13.4.6. By Country 13.5. Market Trends 14. Latin America Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030 14.3.1. By Drug Type 14.3.2. By Indication 14.3.3. By Route of Administration 14.3.4. By Schedule of Drug 14.3.5. By Distribution Channel 14.3.6. By Country 14.3.6.1. Brazil 14.3.6.2. Mexico 14.3.6.3. Argentina 14.3.6.4. Rest of Latin America 14.4. Market Attractiveness Analysis 14.4.1. By Drug Type 14.4.2. By Indication 14.4.3. By Route of Administration 14.4.4. By Schedule of Drug 14.4.5. By Distribution Channel 14.4.6. By Country 14.5. Market Trends 15. Europe Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030 15.3.1. By Drug Type 15.3.2. By Indication 15.3.3. By Route of Administration 15.3.4. By Schedule of Drug 15.3.5. By Distribution Channel 15.3.6. By Country 15.3.6.1. Germany 15.3.6.2. Italy 15.3.6.3. France 15.3.6.4. U.K. 15.3.6.5. Spain 15.3.6.6. Russia 15.3.6.7. Rest of Europe 15.4. Market Attractiveness Analysis 15.4.1. By Drug Type 15.4.2. By Indication 15.4.3. By Route of Administration 15.4.4. By Schedule of Drug 15.4.5. By Distribution Channel 15.4.6. By Country 15.5. Market Trends 16. South Asia Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030 16.3.1. By Drug Type 16.3.2. By Indication 16.3.3. By Route of Administration 16.3.4. By Schedule of Drug 16.3.5. By Distribution Channel 16.3.6. By Country 16.3.6.1. India 16.3.6.2. Thailand 16.3.6.3. Indonesia 16.3.6.4. Malaysia 16.3.6.5. Rest of South Asia 16.4. Market Attractiveness Analysis 16.4.1. By Drug Type 16.4.2. By Indication 16.4.3. By Route of Administration 16.4.4. By Schedule of Drug 16.4.5. By Distribution Channel 16.4.6. By Country 16.5. Market Trends 17. East Asia Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030 17.3.1. By Drug Type 17.3.2. By Indication 17.3.3. By Route of Administration 17.3.4. By Schedule of Drug 17.3.5. By Distribution Channel 17.3.6. By Country 17.3.6.1. China 17.3.6.2. Japan 17.3.6.3. South Korea 17.4. Market Attractiveness Analysis 17.4.1. By Drug Type 17.4.2. By Indication 17.4.3. By Route of Administration 17.4.4. By Schedule of Drug 17.4.5. By Distribution Channel 17.4.6. By Country 17.5. Market Trends 18. Oceania Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030 18.3.1. By Drug Type 18.3.2. By Indication 18.3.3. By Route of Administration 18.3.4. By Schedule of Drug 18.3.5. By Distribution Channel 18.3.6. By Country 18.3.6.1. Australia 18.3.6.2. New Zealand 18.4. Market Attractiveness Analysis 18.4.1. By Drug Type 18.4.2. By Indication 18.4.3. By Route of Administration 18.4.4. By Schedule of Drug 18.4.5. By Distribution Channel 18.4.6. By Country 18.5. Market Trends 19. Middle East and Africa Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022–2030 19.3.1. By Drug Type 19.3.2. By Indication 19.3.3. By Route of Administration 19.3.4. By Schedule of Drug 19.3.5. By Distribution Channel 19.3.6. By Country 19.3.6.1. GCC Countries 19.3.6.2. Turkey 19.3.6.3. Northern Africa 19.3.6.4. South Africa 19.3.6.5. Rest of Middle East and Africa 19.4. Market Attractiveness Analysis 19.4.1. By Drug Type 19.4.2. By Indication 19.4.3. By Route of Administration 19.4.4. By Schedule of Drug 19.4.5. By Distribution Channel 19.4.6. By Country 19.5. Market Trends 20. Key and Emerging Countries Vaginitis Treatment Drugs Market Analysis 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Vaginitis Treatment Drugs Market Analysis 20.2.1. By Drug Type 20.2.2. By Indication 20.2.3. By Route of Administration 20.2.4. By Schedule of Drug 20.2.5. By Distribution Channel 20.3. Canada Vaginitis Treatment Drugs Market Analysis 20.3.1. By Drug Type 20.3.2. By Indication 20.3.3. By Route of Administration 20.3.4. By Schedule of Drug 20.3.5. By Distribution Channel 20.4. Mexico Vaginitis Treatment Drugs Market Analysis 20.4.1. By Drug Type 20.4.2. By Indication 20.4.3. By Route of Administration 20.4.4. By Schedule of Drug 20.4.5. By Distribution Channel 20.5. Brazil Vaginitis Treatment Drugs Market Analysis 20.5.1. By Drug Type 20.5.2. By Indication 20.5.3. By Route of Administration 20.5.4. By Schedule of Drug 20.5.5. By Distribution Channel 20.6. Germany Vaginitis Treatment Drugs Market Analysis 20.6.1. By Drug Type 20.6.2. By Indication 20.6.3. By Route of Administration 20.6.4. By Schedule of Drug 20.6.5. By Distribution Channel 20.7. Italy Vaginitis Treatment Drugs Market Analysis 20.7.1. By Drug Type 20.7.2. By Indication 20.7.3. By Route of Administration 20.7.4. By Schedule of Drug 20.7.5. By Distribution Channel 20.8. France Vaginitis Treatment Drugs Market Analysis 20.8.1. By Drug Type 20.8.2. By Indication 20.8.3. By Route of Administration 20.8.4. By Schedule of Drug 20.8.5. By Distribution Channel 20.9. U.K. Vaginitis Treatment Drugs Market Analysis 20.9.1. By Drug Type 20.9.2. By Indication 20.9.3. By Route of Administration 20.9.4. By Schedule of Drug 20.9.5. By Distribution Channel 20.10. Spain Vaginitis Treatment Drugs Market Analysis 20.10.1. By Drug Type 20.10.2. By Indication 20.10.3. By Route of Administration 20.10.4. By Schedule of Drug 20.10.5. By Distribution Channel 20.11. Russia Vaginitis Treatment Drugs Market Analysis 20.11.1. By Drug Type 20.11.2. By Indication 20.11.3. By Route of Administration 20.11.4. By Schedule of Drug 20.11.5. By Distribution Channel 20.12. China Vaginitis Treatment Drugs Market Analysis 20.12.1. By Drug Type 20.12.2. By Indication 20.12.3. By Route of Administration 20.12.4. By Schedule of Drug 20.12.5. By Distribution Channel 20.13. Japan Vaginitis Treatment Drugs Market Analysis 20.13.1. By Drug Type 20.13.2. By Indication 20.13.3. By Route of Administration 20.13.4. By Schedule of Drug 20.13.5. By Distribution Channel 20.14. South Korea Vaginitis Treatment Drugs Market Analysis 20.14.1. By Drug Type 20.14.2. By Indication 20.14.3. By Route of Administration 20.14.4. By Schedule of Drug 20.14.5. By Distribution Channel 20.15. India Vaginitis Treatment Drugs Market Analysis 20.15.1. By Drug Type 20.15.2. By Indication 20.15.3. By Route of Administration 20.15.4. By Schedule of Drug 20.15.5. By Distribution Channel 20.16. Australia Vaginitis Treatment Drugs Market Analysis 20.16.1. By Drug Type 20.16.2. By Indication 20.16.3. By Route of Administration 20.16.4. By Schedule of Drug 20.16.5. By Distribution Channel 20.17. New Zealand Vaginitis Treatment Drugs Market Analysis 20.17.1. By Drug Type 20.17.2. By Indication 20.17.3. By Route of Administration 20.17.4. By Schedule of Drug 20.17.5. By Distribution Channel 20.18. GCC Countries Vaginitis Treatment Drugs Market Analysis 20.18.1. By Drug Type 20.18.2. By Indication 20.18.3. By Route of Administration 20.18.4. By Schedule of Drug 20.18.5. By Distribution Channel 20.19. Turkey Vaginitis Treatment Drugs Market Analysis 20.19.1. By Drug Type 20.19.2. By Indication 20.19.3. By Route of Administration 20.19.4. By Schedule of Drug 20.19.5. By Distribution Channel 20.20. South Africa Vaginitis Treatment Drugs Market Analysis 20.20.1. By Drug Type 20.20.2. By Indication 20.20.3. By Route of Administration 20.20.4. By Schedule of Drug 20.20.5. By Distribution Channel 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Deep Dive 22.2.1. Abbott Laboratories 22.2.2. Baxter International Inc. 22.2.3. B. Braun Melsungen AG 22.2.4. Allergan AG 22.2.5. Johnson & Johnson 22.2.6. Prestige Consumer Healthcare, Inc. 22.2.7. Sanofi SA 22.2.8. Merck & Co Inc. 22.2.9. Aurobindo Pharma Limited 22.2.10. Mylan NV 22.2.11. Sun Pharmaceutical Industries Limited 22.2.12. Pfizer Inc. 22.2.13. Teva Pharmaceutical Industries Ltd 22.2.14. Bayer AG 22.2.15. Dr. Reddy's Laboratories Ltd 22.2.16. Novartis International AG 22.2.17. Cipla Ltd. 22.2.18. Bausch & Lomb Incorporated 22.2.19. Galderma S.A. 22.2.20. Bristol Myers Squibb Company 22.2.21. Perrigo Company plc. 22.2.22. Lupin Pharmaceuticals, Inc. 22.2.23. Glenmark Pharmaceuticals Inc. 22.2.24. Eurofins Scientific SE 22.2.25. Apotex Inc. 23. Assumptions and Acronyms Used 24. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type Table 02: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 , By Indication Table 03: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration Table 04: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug Table 05: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel Table 06: Global Vaginitis Treatment Drugs Market Analysis 2015-2021 and Forecast 2022–2030, By Region Table 07: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country Table 08: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type Table 09: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication Table 10: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration Table 11: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug Table 12: North America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel Table 13: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country Table 14: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type Table 15: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication Table 16: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration Table 17: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug Table 18: Latin America Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel Table 19: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country Table 20: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type Table 21: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication Table 22: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration Table 23: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug Table 24: Europe Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel Table 25: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country Table 26: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type Table 27: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication Table 28: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration Table 29: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug Table 30: South Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel Table 31: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country Table 32: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type Table 33: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication Table 34: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration Table 35: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug Table 36: East Asia Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel Table 37: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country Table 38: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type Table 39: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication Table 40: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration Table 41: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug Table 42: Oceania Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel Table 43: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015–2021 and Forecast 2022–2030 , By Country Table 44: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Drug Type Table 45: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Indication Table 46: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Route of Administration Table 47: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Schedule of Drug Table 48: Middle East & Africa Vaginitis Treatment Drugs Market Value (US$ Mn) Analysis 2015-2021 and Forecast 2022–2030 , By Distribution Channel
Figure 01: Global Vaginitis Treatment Drugs Market Value Analysis, 2015–2021 Figure 02: Global Vaginitis Treatment Drugs Market Forecast & Y-o-Y Growth, 2022–2030 Figure 03: Global Vaginitis Treatment Drugs Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2030 Figure 04: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis, 2021–2030 Figure 05: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Drug Type Figure 06: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Drug Type Figure 07: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Drug Type Figure 08: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Indication Figure 09: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Indication Figure 10: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Indication Figure 11: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Route of Administration Figure 12: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Route of Administration Figure 13: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Route of Administration Figure 14: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Schedule of Drug Figure 15: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Schedule of Drug Figure 16: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Schedule of Drug Figure 17: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Distribution Channel Figure 18: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Distribution Channel Figure 19: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Distribution Channel Figure 20: Global Vaginitis Treatment Drugs Market Value Share (%) Analysis 2022 & 2030, By Region Figure 21: Global Vaginitis Treatment Drugs Market Y-o-Y Growth (%) Analysis 2021-2030, By Region Figure 22: Global Vaginitis Treatment Drugs Market Attractiveness Analysis 2022–2030 , By Region Figure 23: North America Vaginitis Treatment Drugs Market Value Analysis, 2015–2021 Figure 24: North America Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030 Figure 25: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type Figure 26: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication Figure 27: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration Figure 28: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug Figure 29: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel Figure 30: North America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country Figure 31: Latin America Vaginitis Treatment Drugs Market Value Analysis, 2015–2021 Figure 32: Latin America Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030 Figure 33: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type Figure 34: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication Figure 35: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration Figure 36: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug Figure 37: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel Figure 38: Latin America Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country Figure 39: Europe Vaginitis Treatment Drugs Market Value Analysis, 2015–2021 Figure 40: Europe Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030 Figure 41: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type Figure 42: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication Figure 43: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration Figure 44: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug Figure 45: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel Figure 46: Europe Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country Figure 47: South Asia Vaginitis Treatment Drugs Market Value Analysis, 2015–2021 Figure 48: South Asia Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030 Figure 49: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type Figure 50: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication Figure 51: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration Figure 52: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug Figure 53: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel Figure 54: South Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country Figure 55: East Asia Vaginitis Treatment Drugs Market Value Analysis, 2015–2021 Figure 56: East Asia Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030 Figure 57: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type Figure 58: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication Figure 59: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration Figure 60: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug Figure 61: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel Figure 62: East Asia Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country Figure 63: Oceania Vaginitis Treatment Drugs Market Value Analysis, 2015–2021 Figure 64: Oceania Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030 Figure 65: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type Figure 66: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication Figure 67: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration Figure 68: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug Figure 69: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel Figure 70: Oceania Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country Figure 71: Middle East & Africa Vaginitis Treatment Drugs Market Value Analysis, 2015–2021 Figure 72: Middle East & Africa Vaginitis Treatment Drugs Market Forecast & Y-o-Y growth, 2022–2030 Figure 73: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Drug Type Figure 74: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Indication Figure 75: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Route of Administration Figure 76: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Schedule of Drug Figure 77: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Distribution Channel Figure 78: Middle East & Africa Vaginitis Treatment Drugs Market Attractiveness Analysis, By Country Figure 79: U.S. Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 80: U.S. Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 81: U.S. Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 82: U.S. Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 83: U.S. Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 84: Canada Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 85: Canada Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 86: Canada Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 87: Canada Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 88: Canada Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 89: Mexico Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 90: Mexico Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 91: Mexico Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 92: Mexico Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 93: Mexico Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 94: Brazil Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 95: Brazil Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 96: Brazil Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 97: Brazil Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 98: Brazil Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 99: U.K. Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 100: U.K. Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 101: U.K. Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 102: U.K. Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 103: U.K. Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 104: Germany Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 105: Germany Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 106: Germany Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 107: Germany Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 108: Germany Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 109: France Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 110: France Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 111: France Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 112: France Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 113: France Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 114: Italy Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 115: Italy Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 116: Italy Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 117: Italy Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 118: Italy Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 119: Spain Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 120: Spain Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 121: Spain Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 122: Spain Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 123: Spain Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 124: Russia Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 125: Russia Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 126: Russia Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 127: Russia Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 128: Russia Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 129: China Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 130: China Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 131: China Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 132: China Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 133: China Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 134: Japan Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 135: Japan Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 136: Japan Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 137: Japan Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 138: Japan Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 139: South Korea Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 140: South Korea Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 141: South Korea Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 142: South Korea Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 143: South Korea Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 144: India Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 145: India Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 146: India Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 147: India Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 148: India Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 149: Australia Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 150: Australia Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 151: Australia Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 152: Australia Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 153: Australia Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 154: New Zealand Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 155: New Zealand Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 156: New Zealand Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 157: New Zealand Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 158: New Zealand Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 159: GCC Countries Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 160: GCC Countries Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 161: GCC Countries Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 162: GCC Countries Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 163: GCC Countries Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 164: Turkey Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 165: Turkey Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 166: Turkey Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 167: Turkey Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 168: Turkey Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A Figure 169: South Africa Vaginitis Treatment Drugs Market Share Analysis (%), By Drug Type, 2021A Figure 170: South Africa Vaginitis Treatment Drugs Market Share Analysis (%), By Indication, 2021A Figure 171: South Africa Vaginitis Treatment Drugs Market Share Analysis (%), By Distribution Channels, 2021A Figure 172: South Africa Vaginitis Treatment Drugs Market Share Analysis (%), By Route of Administration, 2021A Figure 173: South Africa Vaginitis Treatment Drugs Market Share Analysis (%), By Schedule of Drug, 2021A
Recommendations
Explore Healthcare Insights
View Reports